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a b s t r a c t 
Single cardiomyocytes are widely used for investigations of the cellular and molecular mechanisms of regulation 
and modulation of cardiac performance. Intact cardiomyocytes allow one to study in detail cell function avoiding 
the effects of extracellular matrix and neighboring cells. The most established protocols of cardiomyocyte 
isolation are based on the isolated heart perfusion using a Langendorff-apparatus or on intraventricular perfusion 
using a syringe. However, the yield of single cardiomyocytes obtained by these methods may be low due to the 
cell injury following non-uniform enzyme digestion of connective tissue in different heart chambers. Moreover, 
isolation of atrial cardiomyocytes is challenging because of their small size and complex geometric shape. Here 
we present a new protocol for simultaneous isolation of high quality cardiomyocytes from the atria, ventricular 
free walls and interventricular septum. The protocol is based on the combination of the Langendorff perfusion 
method with the intraventricular and intra-atrial injection technique taking into account the collagen content 
variation between the different heart chambers. Obtained cells demonstrate rod-shaped morphology, a clear and 
regular sarcomere striation pattern and rat-specific frequency-dependence of contraction and calcium transient 
parameters. Our protocol provides gentle cell isolation that increases the yield of single cardiomyocytes suitable 
for biophysical researches . 
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Subject area Medicine and dentistry 
More specific 
subject area 
Single cell biophysics, single cell biomechanics 
Method name Langendorff-injection 
Protocol name Combined “Langendorff-injection” technique 
Reagents/tools Reagents: 
• NaCl (Acros Organics, Belgium); 
• KCl (Acros Organics, Belgium); 
• KH 2 PO 4 (Acros Organics, Belgium); 
• NaHCO 3 (Acros Organics, Belgium); 
• NaOH (Acros Organics, Belgium); 
• Adenosine (Acros Organics, Belgium), 
• MgSO 4 (Sigma Aldrich, USA); 
• CaCl 2 solution (1 M in H 2 O) (Sigma Aldrich, USA); 
• EGTA (Sigma Aldrich, USA); 
• HEPES (Sigma Aldrich, USA); 
• D-Glucose (Sigma Aldrich, USA); 
• Taurine (Sigma Aldrich, USA); 
• Bovine Serum Albumin (Sigma Aldrich, USA); 
• Protease XIV~3.5 U/mg (Sigma Aldrich, USA); 
• Collagenase Type 2 ~305 U/mg (Worthington, USA); 
• Heparin Sodium 50 0 0 IU/mL (Ellara, Russia); 
• Xylazine 2% (Alfasan, Netherlands); 
• Zoletil-100 (Virbac, France); 
• O 2 (95%) / CO 2 (5%) mixture gas. 
Laboratory equipment and instruments: 
• Electronic Balance Pioneer (Ohaus, USA); 
• pH-meter Starter 2100 (Ohaus, USA); 
• Langendorff-apparatus (custom-made); 
• Peristaltic pump (MasterFlex, USA); 
• Thermostatic water bath (IKA® ICC basic, Germany); 
• Magnetic stirrer with hotplate MR Hei-Standard (Heidolph Instruments, Germany); 
• Centrifuge CM-6MT (ELMI, Latvia) 
• Petri dish with aortic stand and steel hooks to fix the heart (custom-made) 
• 5 small Petri dishes (to collect separately tissue from the left and right atria, left and right 
ventricular free walls and interventricular septum); 
• Big and small scissors; 
• 2 fine precision tweezers with curved tips; 
• Alligator clips and ligature thread; 
• 4 insulin syringes (1 for intra-atrial injection during retrograde perfusion on the 
Langendorff-apparatus, 1 for the intraventricular injection in the custom-made Petri dish; 2 for 
separate injection into the left and right atria); 
• Mesh for single cell filtration 
Experimental 
design 
The protocol consists of 6 steps: 
Step 1: the preparation of the heart for perfusion; 
Step 2: retrograde heart perfusion using a Langendorff-apparatus; 
Step 3: combined Langendorff-injection perfusion; 
Step 4: intraventricular injections; 
Step 5: separations of the heart chambers and additional intra-atrial injections; 
Step 6: preparation and collection of the single cell suspensions. 
Trial registration None 
Ethics Directive 2010/63/EU and local Institutional Ethics Committee (Institute of Immunology and 
Physiology, Ural branch of Russian Academy of Science) 
Value of the 
Protocol 
1. The new protocol provides the gentle and reliable method for simultaneous isolation of highly 
viable intact cardiomyocytes from the atria, ventricular free walls and interventricular septum 
suitable for biophysical and biomechanical studies. 
2. Our isolation protocol takes into account the collagen content variation between the different 
heart chambers that enables to significantly increase the cell yield; 
3. The combination of Langendorff-based and Langendorff-free methods allows one to keep the 
advantages of each technique providing greater productivity. 



































escription of protocol 
ationale 
An isolated cardiac myocyte is the essential research object to study in detail the intrinsic
ellular and sub-cellular mechanisms of cardiac output regulation. The most established protocols of
ingle cardiomyocyte isolation are based on the standard Langendorff retrograde perfusion [1–3] or
implified intraventricular injection technique [3–6] . However, these methods do not take into account
he variation in the connective tissue content between the heart chambers [7–9] , which affects the
ield of obtained viable cells. Here, we present an alternative protocol of simultaneous isolation of
ighly viable single cardiomyocytes from atria, ventricular free walls and interventricular septum
sing the combination of retrograde Langendorff-based perfusion and the intraventricular and intra-
trial injection technique with varying concentration of enzyme solution. 
Laboratory equipment and instruments: 
Electronic Balance Pioneer (Ohaus, USA); 
pH-meter Starter 2100 (Ohaus, USA); 
Langendorff-apparatus (custom-made) ( Fig.1 A); 
Peristaltic pump (MasterFlex, USA); 
Thermostatic water bath (IKA® ICC basic, Germany); 
Magnetic stirrer with hotplate MR Hei-Standard (Heidolph Instruments, Germany); 
Centrifuge CM-6MT (ELMI, Latvia) 
Petri dish with aortic stand and steel hooks to fix the heart (custom-made) ( Fig. 1 B) 
5 small Petri dishes (to collect separately tissue from the left and right atria, left and right
ventricular free walls and interventricular septum); 
Big and small scissors; 
2 fine precision tweezers with curved tips; 
Alligator clips and ligature thread; 
4 insulin syringes (1 for intra-atrial injection during retrograde perfusion on the Langendorff-
apparatus, 1 for intraventricular injection in the custom-made Petri dish; 2 for separate injection
into the left and right atria); 
Mesh for single cell filtration 
eagents 
rocedure 
All experiments were carried out according to the Directive 2010/63/EU and approved by Animal
are and Use Committee of the Institute of Immunology and Physiology of RAS.. Adult Wistar rats,ig. 1. A Langendorff-apparatus (A) for retrograde perfusion and a custom-made Petri dish with aortic stand and steel hooks 
B) for the injection technique. 
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Table 1 
Krebs-Henseleit bicarbonate buffer (K-H buffer). 
Compound Molar Weight (g/M) Final concentration (mM) 
NaCl 58.44 121 
KCl 74.55 4.7 
MgSO 4 120.37 1.2 
KH 2 PO 4 136.09 1.2 
NaHCO 3 84.01 19.0 
HEPES 238.30 10.0 
Taurine 125.15 20.0 
Adenosine 267.24 2.0 
d-Glucose 180.20 11.1 
CaCl 2 110.98 1.0 
pH 7.25 with NaOH at 35 °C. 
95% O 2 + 5% CO 2 for 30 min before pH calibration. 























aged 3–6 months, are maintained under standard conditions before their use in experiments. The rats
are injected intramuscularly with heparin sodium (50 0 0 IU/kg) to prevent development of coronary
thrombosis, anesthetized 20 min later with Zoletil (0.3 mL/kg) and Xylazine (1 mL/kg) and euthanized
in 15–20 min. 
Step 1 – Preparation of the heart for perfusion 
After euthanasia, the chest is rapidly opened, and the heart is flashed with heparin-containing cold
(10–15 °C) K-H buffer ( Table 1 ). Then the heart is immediately removed together with the lungs and
placed in cold K-H buffer. Note, that it is important to do not cut completely the descending aorta,
pulmonary trunk, as well as the venae cavae and pulmonary veins, to be able to easily change the
heart pressure (see Step 2). We also do not remove the pericardium to prevent possible ischemic
effects during the heart stabilization on a Langendorff-apparatus. 
Step 2 – Retrograde heart perfusion using a Langendorff-apparatus 
The heart is swiftly transferred to a switched-on Langendorff perfusion apparatus and the aorta is 
cannulated ( < 30 s), fixed with an alligator clip and tightly tied with the ligature thread to the cannula.
Perfusion is conducted at 35.5 °C at a rate of ~ 4.0–4.5 mL/min (depends on the heart size) with a
sequence of three solutions ( Tables 1 –3 ) equilibrated with 95% O 2 + 5% CO 2 ( Fig. 2 ). Perfusion is started
with heparinized K-H buffer for 5 min after the heart has started normal beating (80–110 beat/min)
to wash out from blood and maintain the isolated heart in vitro conditions. During perfusion with K-H
buffer, the pulmonary trunk and veins are not ligated to prevent pressure overload ( Fig. 2 A). 
If the coronary flow and heart beating are sufficient, perfusion is switched to low Ca 2 + - high K + 
K-H buffer ( Table 2 ) for 10 min after the heart has stopped beating. When the heart is completely
stopped the perfusion flow rate should be slightly increased (up to 4.5–5.0 mL/min) and the
pulmonary trunk and a vena cava should be ligated to enhance the flow and intra-atrial pressure
( Fig. 2 B). The hallmarks of sufficient atrial perfusion are an increase in their size (a right atrium is
usually larger than the left one) and a change in their color from deep to pale. case if the right atrium
is swollen due to the pressure overload, the ligature is removed or the right atrium surface is slightly
incised. 
Step 3 – Combined Langendorff-injection perfusion 
Next, the heart is perfused with a Low-concentrated Enzyme solution for 10–15 min 
( Table 2 ) for enzymatic disruption of intercellular contacts at the intercalated discs. The perfusion
flow rate should be again slightly increased (up to 5.2–5.5 mL/min). In 2–2.5 min later each atrium is
injected (0.5–1 mL/min) with a High-concentrated Enzyme solution ( Table 3 ) using an insulin syringe
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Table 2 
Low Ca 2 + - high K + Krebs-Henseleit bicarbonate buffer, Low-concentrated Enzyme solution and Stopping buffer. 





NaCl (mM) 105 105 105 
KCl (mM) 14.7 14.7 14.7 
MgSO 4 (mM) 5 5 5 
KH 2 PO 4 (mM) 1.2 1.2 1.2 
NaHCO 3 (mM) 10.0 10.0 10.0 
HEPES (mM) 10.0 10.0 10.0 
Taurine (mM) 20.0 20.0 20.0 
Adenosine (mM) 2.0 2.0 2.0 
d-Glucose (mM) 11.1 11.1 11.1 
EGTA (mM) 0.15 — —
CaCl 2 (mM) 0.05 0.025 0.025 








— — 5 
pH with NaOH at 
35 °C 
95% O 2 + 5% CO 2 
for 30 min before 
pH calibration 
7.0 7.25 7.25 
Table 3 
Enzyme solutions. 
Collagenase type II~305 U/mg Protease XIV~3.5 U/mg 
Low-concentrated 0.6 mg/mL 0.06 mg/mL 
High-concentrated 0.8 mg/mL —
Medium-concentrated 3 Low: 1 High 
Fig. 2. Representative illustration of the protocol steps based on the Langendorff method. (A). The heart mounted on a 
Langendorff perfusion apparatus when the aorta is cannulated, fixed with an alligator clip and tied with the ligature thread 
(step 1). (B). The ligation of the pulmonary trunk and inferior vena cava (step 2). (C). The injection of the left and right atria 
with a High-concentrated Enzyme solution (step 3). 
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Fig. 3. Representative illustration of the Langendorff-free injection method. (A). Intraventricular injections (step 4). (B). Intra- 
atrial injections (step 5). ( С ). Tissue disaggregation (step 6). Note the difference in the final structure of disrupted tissue 




















( Fig. 2 C) during continuous retrograde perfusion. Tominimize the mechanical interventions and 
maintain optimal intra-atrial pressure, all injections should be performed at the same puncture site. 
Then the Langendorff-perfusion should be stopped at the half-digested state. This state is 
determined by the pale color of the heart surface, relatively soft heart surface with preserved elasticity
(check it by pushing), and, most important, by the appearance of viscous drops at the apex. In this
stage, the heart should be rapidly transferred to a custom-made Petri dish (see laboratory equipment
and instruments) with a warm (35 ° C) Medium-concentrated Enzyme solution ( Table 3 ) equilibrated
with 95% O 2 + 5% CO 2 . 
Step 4 – Intraventricular injections 
Then the heart is transferred to a Petri dish to perform further perfusion by a syringe. This
approach provides gentle manually controlled digestion of the myocardium from all the chambers. 
In a custom-made Petri dish, the ascending aorta is fixed to the aortic stand by an alligator clip
while the descending aorta and veins are ligated (to mountain optimal perfusion pressure) and fixed
with special hooks. To maintain a stable temperature (35.5 °C) of the solution in a Petri dish we put
it on the hotplate ( Fig. 3 ). In this step, firstly, the heart is perfused only by injections of the left
ventricular apical region using an insulin syringe (7 min, 5–6 mL/min). As previously, all injections
should be performed at the same puncture site ( Fig. 3 A). Then the right ventricle is additionally
perfused by injections into the apical region of the right ventricular free wall (12–15 min). The
interventricular septum is perfused when the syringe needle is inserted completely into the septum 
(2–3 min). As previously, all injections should be performed at the same puncture site ( Fig. 3 A).
It is also important to check that atria gradually increase in their size with each injection. The
intraventricular perfusion is stopped when the signs of complete ventricular digestion are manifested. 
It includes a decrease in tissue resistance to injection flow, soft and glossy epicardial surface, a
characteristic smell, the appearance of holes and extensive pale areas at the epicardium, and the
appearance of single myocytes in the solution. 95% O2 + 5% CO2 was continuously supplied to the
solutions during the entire procedure. 
Step 5 – Separations of the heart chambers. Intra-atrial injections 
After complete digestion of the ventricles, the ligatures are removed and the heart is separated
into 5 regions: the left and right ventricular free walls, interventricular septum, left and right atrium,
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Table 4 
A gradual increase in Ca 2 + concentration. 
Step Solution Calcium concentration 
Step 0 Stopping buffer and Medium-concentrated Enzyme solution (1:1) 25 μM 
Step 1 Stopping buffer 0.10 mM 
Step 2 Stopping buffer 0.25 mM 
Step 3 Stopping buffer 0.40 mM 
Step 4 Stopping buffer 0.90 mM 
Step 5 Hepes-buffered Tyrode 1.8 mM 
Table 5 
Hepes-buffered Tyrode. 
Compound Molar Weight (g/M) Final concentration (mM) 
NaCl 58.44 140 
KCl 74.55 5.4 
MgSO 4 120.37 1 
HEPES 238.30 10.0 
d-Glucose 180.20 11.1 
CaCl 2 110.98 1.8 






























ach of which is quickly transferred in a separate Petri dish. Petri dishes with the left ventricular free
all and interventricular septum contain a Low-concentrated Enzyme solution with Stopping buffer
1:1, Table 2 ) To provide better digestion of the heart regions that have been less perfused, a Petri dish
ith the right ventricular free wall contains a Low-concentrated Enzyme solution and Petri dishes
ith atria contain a High-concentrated Enzyme solution without adding Stopping buffer. 
Then, the ventricular free walls and interventricular septum are exposed to gentle mechanical
isruption, re-suspended with Stopping buffer, filtrated and gradually adjusted to extracellular Ca 2 +
oncentration (see Step 6). The left and right atria, which contain a greater concentration of collagen
han ventricles are exposed to additional enzymatic digestion by intra-atrial injections with a High-
oncentrated Enzyme-solution for 20–24 min using separate syringes ( Fig. 3 B). Notably, the atria
hould not be completely hermetic. The atrioventricular septum was cut but intra-atrial perfusion flow
6–7 mL/min) was sufficient to provide optimal digestion. After the signs of the complete digestion of
he atria are appeared (the same as for the ventricles, see above), the perfusion is stopped, and the
tria are ready for mechanical disruption. 
tep 6 – Preparation and collection of single cell suspensions 
Completely digested atria, free ventricular walls and interventricular septum are accurately
isrupted using small scissors ( Fig. 3 C). A solution, containing ventricular cells, is filtered through
 mesh, re-suspended with Stopping buffer ( Table 2 ) and harvested by gravity sedimentation for
0–12 min. We do not filter the atrial cell suspension centrifuging it instead in Stopping buffer for
 min at 7 × g (200 rpm) before gravity sedimentation. The sedimentation is repeated several times,
hile extracellular Ca 2 + concentration is gradually increased to physiological values (1.8 mM CaCl 2 )
 Table 4 ). The final cell pellet is stored in Hepes-buffered Tyrode solution ( Table 5 ) at room
emperature (22–24 °C). To prevent cell-to-cell adhesion the tubes with cell suspensions are stored
t a 45 ° angle ( Fig. 3 D). 
rotocol validation 
easurements of the functional characteristics 
To evaluate the viability and functional ability of isolated cardiomyocytes, we recorded sarcomere
hortening and cytosolic free calcium transient using the LSM 710 laser confocal scanning microscopy
ystem and Zen 2010 software (Carl Zeiss, Germany). 
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Fig. 4. Representative images of single cardiomyocytes. (A). From the left ventricular free wall. (B). From the interventricular 














For calcium transient recordings, cells from each region were incubated in Tyrode solution 
supplemented with 2.5 μM calcium sensitive dye Fluo-8 AM (AAT Bioquest, USA) and 0.1% Pluronic®
F-127 (AAT Bioquest, USA) in darkness for 20 min at room temperature. Before the measurements,
cells were re-suspended in a dye-free Tyrode solution. An argon laser with a wavelength of 488 nm
was used to excite the fluorescent dye. The emitted fluorescence was collected every 1–3 ms in the
continuous scanning mode at 493–575 nm in a narrow (3 pixels high, 20 0–50 0 pixels long) region
horizontally oriented along the long axis in the center of a cardiomyocyte. The change in fluorescence
intensity ( F/F 0 , where F 0 is the initial fluorescence) was calculated and used as an index of the
change in cell cytosolic calcium concentration using custom-made software EqapAll 6 [10] . 
To record unloaded sarcomere shortening, the image-intensity profile in the selected narrow region 
was obtained in the optical channel. The method of Discrete Fourier Transform of the striation profile
signal was used to determine the average sarcomere length in a cardiomyocyte using EqapAll6. 
The measurements were carried out after the cells reached a steady-state at an electric stimulation
frequency of 1, 2, 3 and 4 Hz at a temperature of the Tyrode solution in the perfusion chamber of
36–37 °C. 
The yield of intact viable cells that can be achieved with our protocol is ≈ 60–90% for ventricular
myocytes and ≈ 40–70% for atrial myocytes that are suitable for various measurements required the 
use of fluorescent dyes or/and drugs. Isolated single cardiomyocytes have a rod-shaped form with 
a clear sarcomere striation pattern and preserved chamber-specific morphology as shown in Fig. 4 .
Obtained myocytes can be used within 8 hours of isolation prior measurements without membrane 
blebbing or loss of functional activity. 
Observed data demonstrate pronounced regional differences in the amplitude and the time course 
of calcium transient and sarcomere shortening between the chambers consistently with [10–12] 
( Fig. 5 ). For ventricular cells, we observed rat-specific frequency-dependent modulation in the 
parameters of cytosolic calcium transient and sarcomere shortening. Both calcium transient decay as 
well as sarcomere relaxation are accelerated with increased pacing frequency as previously shown 
[13–16] . Notably, the discrepancy between the frequency-dependent decrease in the amplitude of 
calcium transient and frequency-independency in the amplitude of sarcomere shortening is consistent 
with the literature data obtained from rats [ 17 , 18 ]. These results indicate normal contractile ability of
obtained cardiomyocytes. 
Conclusions 
The presented protocol provides simultaneous isolation of high yields of healthy viable 
cardiomyocytes from different heart chambers. It can be used for biophysical and biomechanical 
studies, notably in the area of myocardial heterogeneity research. The combination of Langendorff- 
based and Langendorff-free methods allows one to keep the advantages of each technique, such 
as the automation of the experimental protocol with a stable solution flow during the Langendorff
retrograde perfusion and local perfusion control during the intraventricular and intra-atrial injections. 
Additionally, the use of solutions with different enzymatic activity ensures a high success rate for
precise isolation of cells from different heart chambers. 
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Fig. 5. Representative recordings of cytosolic free calcium transient (A) and sarcomere shortening (B) in isolated ventricular 























[  Our protocol was developed taking into account the collagen content in rats. However, due to the
implicity and convenient control of the experimental manipulations, this protocol can be adapted for
ny species. 
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